Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CXCR4”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06183554
What this trial is testing

CXCR4 Targeted PET Imaging in the Diagnosis and Identification of Primary Aldosteronism

Who this might be right for
Primary Aldosteronism
Xiao Chen 60
Testing effectiveness (Phase 2)Study completedNCT00089466
What this trial is testing

Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Very early researchLooking for participantsNCT05093335
What this trial is testing

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Who this might be right for
Non-Hodgkin LymphomaMultiple MyelomaHistiocytic Neoplasms+2 more
Memorial Sloan Kettering Cancer Center 30
Not applicableUnknownNCT00174096
What this trial is testing

The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

Who this might be right for
Laryngeal CancerHypopharyngeal CancerMetastasis
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00082329
What this trial is testing

G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers

Who this might be right for
Healthy
National Heart, Lung, and Blood Institute (NHLBI) 9
Testing effectiveness (Phase 2)Study completedNCT04154488
What this trial is testing

Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders

Who this might be right for
Neutropenia
X4 Pharmaceuticals 32
Very early researchUnknownNCT06086327
What this trial is testing

Application of 68Ga-Pentixafor PET/CT for Thymoma

Who this might be right for
Thymoma
Peking Union Medical College Hospital 100
Early research (Phase 1)Study completedNCT00322127
What this trial is testing

An Evaluation of Safety and Efficacy of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers

Who this might be right for
Healthy Volunteers
National Heart, Lung, and Blood Institute (NHLBI) 44
Not applicableUnknownNCT04799730
What this trial is testing

Expression of CXCR4 in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Sohag University 100
Not applicableStudy completedNCT07316309
What this trial is testing

CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Shandong Cancer Hospital and Institute 33
Not applicableUnknownNCT00302562
What this trial is testing

The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

Who this might be right for
Laryngeal CancerHypopharyngeal Cancer
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07775313
What this trial is testing

Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM

Who this might be right for
WHIMWartsHypogammaglobulinemia+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Looking for participantsNCT07350707
What this trial is testing

Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome

Who this might be right for
Cushing s Syndrome
Peking Union Medical College Hospital 160
Not applicableWithdrawnNCT03087370
What this trial is testing

A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome

Who this might be right for
WHIM Syndrome
X4 Pharmaceuticals
Early research (Phase 1)Ended earlyNCT02737072
What this trial is testing

LY2510924 and Durvalumab in Participants With Solid Tumors

Who this might be right for
Solid Tumor
Eli Lilly and Company 9
Not applicableUnknownNCT00173849
What this trial is testing

The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma

Who this might be right for
Oral Cancer
National Taiwan University Hospital 100
Early research (Phase 1)Study completedNCT01359657
What this trial is testing

Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 46
Not applicableLooking for participantsNCT06871176
What this trial is testing

PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
University Health Network, Toronto 30
Very early researchLooking for participantsNCT04504526
What this trial is testing

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

Who this might be right for
LymphomaMultiple MyelomaLeukemia
First Affiliated Hospital of Fujian Medical University 50
Very early researchLooking for participantsNCT07577206
What this trial is testing

Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.

Who this might be right for
Advanced Solid TumorMultiple Myeloma
National Cancer Institute, Naples 10
Next Page